From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Hepatitis B Advanced Management and Prescribing Course

Delivery mode
Live Online
CPD Hours
9.5
Cost
FREE
11 & 18 Nov, 7:00pm AEDT
Online (National)

Overview

Upon successful completion of this free training and the associated case assessment, participants will increase their confidence in managing and prescribing section 100 (s100) drugs for the management of hepatitis B in Australia and be eligible to display on ASHM’s HBV Prescriber Map.

Click here to view our downloadable flyer!

Date, Time, and Platform:

  • Dates and Times:
    • Part 1: Wednesday, 11 November 2026
      • NSW, ACT, VIC, TAS: 7:00pm – 8:00pm AEDT
      • SA: 6:30pm – 7:30pm ACDT
      • QLD: 6:00pm – 7:00pm AEST
      • NT: 5:30pm – 6:30pm ACST
      • WA: 4:00pm – 5:00pm AWST
    • Part 2: Wednesday, 18 November 2026
      • NSW, ACT, VIC, TAS: 7:00pm – 9:00pm AEDT
      • SA: 6:30pm – 8:30pm ACDT
      • QLD: 6:00pm – 8:00pm AEST
      • NT: 5:30pm – 7:30pm ACST
      • WA: 4:00pm – 6:00pm AWST
  • Platform: Live Online – Zoom

Speakers:

  • Professor Amanda Wade | Infectious Diseases Physician and BBV Medical Lead, Barwon Health | Research Fellow, Burnet Institute | Associate Professor, Barwon Health Deakin University Clinical Trials Alliance
  • Dr Caran Cheung | GP and hepatitis B Prescriber | Mascot Medical

Learning Outcomes:

On completion of this course and its components, participants will be able to:

  • Outline the critical role of primary care in the diagnosis, management and treatment of people living with chronic hepatitis B       
  • Plan long-term care, including guideline-based monitoring and hepatocellular carcinoma screening, for patients with chronic hepatitis B       
  • Select and prescribe first-line antiviral treatment when clinically indicated       
  • Identify situations where specialist advice or referral is required        
  • Integrate principles of person-centred and culturally competent care into hepatitis B management 

Course Components:

  • Pre-course survey  
  • Clinical Extensions of Hepatitis B online learning module  
  • Live online: A program combining self-paced online work with two live online workshops. Please note that all earlier activities must be completed before links to the interactive online workshops are sent. 
  • Post-course online multiple choice assessment 
  • Post-course survey  

CPD and Endorsement:

  • RACGP: This is an approved activity under the RACGP CPD Program. Activity number 1522233.
    7.5 Educational Hours.
    2 Performance Review Hours 
  • ​​ACRRM: This event has been accredited in the 2026-2028 ACRRM CPD Program.  
    7.5 Educational Hours 
    2 Performance Review Hours 
  • ​​ACNP: This activity is endorsed by the Australian College of Nurse Practitioners (ACNP) for  9.5 hours 

Funding:

This course received funding from the Australian Government Department of Health, Disability and Ageing.

Target Audience:

General Practitioners, Nurse Practitioners, other community based medical practitioners based in Australia.   

For more information:

Please contact ASHM Education at [email protected] or call 0431 320 429.

Upcoming Conferences and Events

APSAD 2026

8 - 11 Nov 2026
Esplanade Hotel Fremantle by Rydges, Walyalup (WA, Australia)
Sector Event

The AAAH Youth Health Conference 2027

5 - 7 May 2027
Qt Hotel Gold Coast on Yugambeh Country (QLD, Australia)

17th Australasian Viral Hepatitis Conference

18 - 20 Aug 2027
Novotel Wollongong Northbeach, Dharawal (Wollongong) (NSW, Australia)